CVE-2022-37017

Description

Symantec Endpoint Protection (Windows) agent, prior to 14.3 RU6/14.3 RU5 Patch 1, may be susceptible to a Security Control Bypass vulnerability, which is a type of issue that can potentially allow a threat actor to circumvent existing security controls. This CVE applies narrowly to the Client User Interface Password protection and Policy Import/Export Password protection, if it has been enabled.

7.5

CVSS

Severity: High

CVSS 3.1 •

EPSS 2.80% Top 15%

Vendor Advisory broadcom.com

Affected: n/a Symantec Endpoint Protection

References

Link	Tags
https://support.broadcom.com/web/ecx/support-content-notification/-/external/content/SecurityAdvisories/0/21014	permissions required vendor advisory

Frequently Asked Questions

What is the severity of CVE-2022-37017?: CVE-2022-37017 has been scored as a high severity vulnerability.
How to fix CVE-2022-37017?: To fix CVE-2022-37017, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-37017 being actively exploited in the wild?: It is possible that CVE-2022-37017 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~3% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-37017?: CVE-2022-37017 affects n/a Symantec Endpoint Protection.

This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.